|
| Drug Name |
MENOSTAR |
| Active Ingredient(s) |
ESTRADIOL |
Form(s) and
Strength(s) Available |
SYSTEM; TRANSDERMAL:0 |
Product Information / Press Release Menostar is a new thumbnail-sized, once-a-week patch for osteoporosis preventation.Menostar delivers a very low-dose of estradiol. With only 14 micrograms of estrogen per day, Menostar delivers half of the lowest currently available transdermal estrogen dose. A progestin is generally required for women with a uterus when they use standard, higher doses of estrogen; however, due to Menostars very low dosage, it can be used without a daily or monthly progestin in women with a uterus.
With Menostar, Schering gains tremendous strength in its womens health portfolio. Menostar is an innovative, dramatic shift in post-menopausal osteoporosis prevention addressing both women with and without a uterus, said Dr. Philip Smits, Head of Gynecology & Andrology at Schering AG. Menostar offers a dosage far lower than todays standards. With this convenient patch we can return a womans estrogen to the lowest physiological level proven to prevent bone loss to date.
|
|
Tell a friend about this item!